TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 129.9M
Gross Profit 42.8M 32.99%
Operating Income 3.4M 2.62%
Net Income 906.0K 0.70%

Balance Sheet Metrics

Total Assets 406.2M
Total Liabilities 302.0M
Shareholders Equity 104.2M
Debt to Equity 2.90

Cash Flow Metrics

Revenue & Profitability Trend

Zenlabs Ethica Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i514.2M585.6M668.9M690.9M566.4M
Cost of Goods Sold i372.2M437.9M533.0M563.9M467.3M
Gross Profit i142.0M147.8M135.8M126.9M99.1M
Gross Margin % i27.6%25.2%20.3%18.4%17.5%
Operating Expenses
Research & Development i----339.6K
Selling, General & Administrative i-35.6M31.0M32.4M26.5M
Other Operating Expenses i74.3M43.5M32.4M28.8M18.1M
Total Operating Expenses i74.3M79.1M63.4M61.3M45.0M
Operating Income i13.1M11.2M16.6M15.0M10.4M
Operating Margin % i2.5%1.9%2.5%2.2%1.8%
Non-Operating Items
Interest Income i-585.0K831.0K849.0K957.0K
Interest Expense i9.3M8.0M5.3M3.6M2.8M
Other Non-Operating Income-----
Pre-tax Income i4.3M5.8M6.7M12.2M8.6M
Income Tax i1.6M1.6M1.9M4.4M926.0K
Effective Tax Rate % i37.1%27.6%27.5%36.0%10.8%
Net Income i2.7M4.2M4.9M7.8M7.7M
Net Margin % i0.5%0.7%0.7%1.1%1.4%
Key Metrics
EBITDA i26.2M24.6M30.3M24.8M18.7M
EPS (Basic) i-₹0.65₹0.75₹1.20₹1.18
EPS (Diluted) i-₹0.65₹0.75₹1.20₹1.18
Basic Shares Outstanding i-6510015651001565100156510015
Diluted Shares Outstanding i-6510015651001565100156510015

Income Statement Trend

Zenlabs Ethica Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i17.9M9.0M545.0K93.0K882.0K
Short-term Investments i2.3M2.4M3.2M678.0K1.3M
Accounts Receivable i195.4M207.3M217.0M207.4M188.8M
Inventory i131.0M120.0M113.7M86.6M51.8M
Other Current Assets27.0M16.8M20.9M23.5M20.2M
Total Current Assets i373.5M355.5M375.0M334.0M274.9M
Non-Current Assets
Property, Plant & Equipment i22.9M2.1M2.1M2.1M2.1M
Goodwill i----0
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets--80.0K-6
Total Non-Current Assets i32.7M47.1M59.9M45.0M47.1M
Total Assets i406.2M402.6M434.9M379.0M322.0M
Liabilities
Current Liabilities
Accounts Payable i142.8M121.4M254.2M218.3M192.4M
Short-term Debt i121.3M132.7M28.2M18.2M7.0M
Current Portion of Long-term Debt-----
Other Current Liabilities2.9M3.4M824.0K1.1M730.0K
Total Current Liabilities i281.2M270.2M294.5M252.0M214.5M
Non-Current Liabilities
Long-term Debt i5.7M15.9M30.3M20.8M19.0M
Deferred Tax Liabilities i----0
Other Non-Current Liabilities-----
Total Non-Current Liabilities i20.7M31.1M43.4M33.6M21.8M
Total Liabilities i302.0M301.4M337.9M285.6M236.4M
Equity
Common Stock i65.1M65.1M65.1M65.1M65.1M
Retained Earnings i-36.1M31.9M28.2M20.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i104.2M101.2M97.0M93.3M85.6M
Key Metrics
Total Debt i127.0M148.6M58.4M39.0M26.0M
Working Capital i92.3M85.2M80.5M82.0M60.4M

Balance Sheet Composition

Zenlabs Ethica Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i4.3M5.8M6.7M12.2M8.6M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-8.7M16.0M-48.3M-53.0M-132.6M
Operating Cash Flow i4.8M29.5M-31.3M-37.9M-122.1M
Investing Activities
Capital Expenditures i1.5M--0600.0K
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i1.5M--0601.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i---1.6M--
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-7.8M103.3M2.5M12.6M-10
Free Cash Flow i38.1M-90.8M-264.0K-4.1M-84.1M
Net Change in Cash i-1.5M132.9M-28.8M-25.3M-121.5M

Cash Flow Trend

Zenlabs Ethica Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 78.02
Price to Book 1.99
Price to Sales 0.42

Profitability Ratios

Profit Margin 0.52%
Operating Margin 2.62%
Return on Equity 2.62%
Return on Assets 2.02%

Financial Health

Current Ratio 1.33
Debt to Equity 121.85
Beta -0.77

Per Share Data

EPS (TTM) ₹0.41
Book Value per Share ₹16.09
Revenue per Share ₹78.32

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
zenlabs214.6M78.021.992.62%0.52%121.85
Entero Healthcare 51.9B54.823.015.36%1.90%21.76
Amwill Health Care 1.2B8.971.7224.85%26.44%0.00
Royal Sense 1.1B17.333.6227.55%10.26%11.74
NOVELIX 532.4M514.502.340.68%0.28%0.00
Trimurthi 264.8M102.352.400.00%1.85%-

Financial data is updated regularly. All figures are in the company's reporting currency.